Clinical trial for Endometriosis
Official title Multimodal Physiotherapy Based on Tele-rehabilitation in Chronic Pelvic Pain Associated With Endometriosis
ClinicalTrials.gov ID: NCT06209346
What this study is testing
- What it's testing
- Objective: To determine if the tele-rehabilitation program for chronic pelvic pain associated with endometriosis composed of pain education, therapeutic exercise and respiratory control decreases pain according to the Visual Numerical Scale (EVN), catastrophizing with the Pain Catastrophizing Scale (PCS), kinesiophobia with the Tampa Scale of Kinesiophobia (TSK), improves sexual function according to the Female Sexual Function Index (FSFI) and QoL compared to the Control Group with the Health Status Questionnaire (SF-12). Follow-up: four evaluated questionnaires: preintervention; postintervention, 3 months postintervention, 6 months postintervention Participants: 66 women diagnosed with endometriosis with chronic pelvic pain in different Spanish endometriosis associations.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55, women only
You may be able to join if
- Women with a medical diagnosis of endometriosis.
- Age equal to or older than 18 years and up to 55 years.
- Who are or have received medical and/or surgical treatment and with controlled disease.
- Persistent pelvic pain for at least 3 months.
- Pain greater than 4 on the EVN.
You likely can't join if
- Peri- and postmenopausal women.
- Women pregnant or desiring gestation during the study.
- Women with a history of gynecologic cancer and/or undergoing any systemic and/or localized oncologic treatment in the pelviperineal region
- Women with a diagnosis of chronic fatigue or fibromyalgia▪.
- Women concomitantly participating in another intervention study.
- Women undergoing surgery during the study.
See the full eligibility criteria
- Women with a medical diagnosis of endometriosis.
- Age equal to or older than 18 years and up to 55 years.
- Who are or have received medical and/or surgical treatment and with controlled disease.
- Persistent pelvic pain for at least 3 months.
- Pain greater than 4 on the EVN.
- No cognitive limitation to understand the information sheet, instructions and freely sign the informed consent
- Have any electronic device available (tablet, computer, cell phone).
- Have a current email address.
- Have a valid e-mail address.
- Peri- and postmenopausal women.
- Women pregnant or desiring gestation during the study.
- Women with a history of gynecologic cancer and/or undergoing any systemic and/or localized oncologic treatment in the pelviperineal region
- Women with a diagnosis of chronic fatigue or fibromyalgia▪.
- Women concomitantly participating in another intervention study.
- Women undergoing surgery during the study.
The study team makes the final eligibility decision.
Where it's taking place
- Alcalà de Henares, Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alcalà de Henares, Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.